ArticleSignal transduction and targeted therapy2026

iS2C2: a cointelligent platform for mechanistic discovery of disease cellular crosstalk.

Jianting Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.